Abeona Therapeutics Inc. (ABEO)
$4.94-0.40%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $282M
- Beta
- 1.30
- P/E (TTM)
- -4.41
- Short % float
- 46.11%
- Days to cover
- 11.6
- SI change
- +7.2%
- 1W
- -1.79%
- 1M
- -9.85%
- vs SPY 1W
- -2.95%
- vs SPY 1M
- -12.85%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ABEO?
- LOPJLB’s latest quantitative signal on Abeona Therapeutics Inc. (ABEO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ABEO in?
- Abeona Therapeutics Inc. (ABEO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Abeona Therapeutics Inc. (ABEO) do?
- Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also fe…